导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 33.23% | 115/1050 |
| 近一周 | -3.77% | 939/1104 |
| 近一月 | -8.71% | 970/1102 |
| 近一季 | -19.29% | 959/1092 |
| 近半年 | 20.15% | 138/1070 |
| 近一年 | 41.00% | 105/1018 |
| 近两年 | 151.98% | 97/926 |
| 近三年 | 97.46% | 95/834 |
| 成立以来 | 283.90% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
5.22% 138/1070 |
91.75% 68/1101 |
- - |
- - |
| 2025 | 56.99% 131/1065 |
5.10% 407/1014 |
4.16% 352/1038 |
41.78% 162/1050 |
1.14% 382/1065 |
| 2024 | -2.49% 644/1011 |
-4.31% 544/960 |
-3.16% 516/983 |
8.44% 754/991 |
-2.96% 532/1011 |
| 2023 | -13.36% 451/952 |
7.74% 178/880 |
-4.82% 510/895 |
-12.31% 694/915 |
-3.64% 383/952 |
| 2022 | -23.97% 464/867 |
-14.49% 232/773 |
1.92% 665/806 |
-8.46% 163/845 |
-4.70% 636/867 |
| 2021 | 33.22% 54/740 |
-3.98% 304/580 |
16.93% 208/659 |
14.76% 35/704 |
3.39% 285/740 |
| 2020 | 70.55% 142/554 |
-1.93% 214/419 |
26.98% 162/466 |
10.62% 236/517 |
23.79% 81/554 |
| 2019 | 63.83% 63/410 |
37.91% 89/1146 |
2.69% 128/1228 |
7.00% 162/390 |
8.12% 234/410 |
| 2018 | -30.14% 217/349 |
- - |
-10.70% 524/990 |
-9.82% 754/1000 |
-8.29% 168/1080 |
| 2017 | 18.59% 87/285 |
- - |
- - |
- - |
- - |
| 2016 | -13.71% 84/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 建信信息产业股票A VS. 东吴新产业精选股票A(580008) |